E-LIB Suche - Ergebnisse für: Shukui Qin

1

Polymorphisms in XRCC1 and XPG and response to platinum-bas..:

Sun, Xinchen ; Li, Fan ; Sun, Ning...
Lung Cancer. 65 (2009) 2 - p. 230-236 , 2009

Link: https://doi.org/10.1016/..

2

GS-005 mRECIST outcomes in EMERALD-1: a phase 3, randomized..:

Sangro, Bruno ; Kudo, Masatoshi ; Erinjeri, Joseph...
Journal of Hepatology. 80 (2024) - p. S3 , 2024

Link: https://doi.org/10.1016/..

3

Bemarituzumab plus mFOLFOX6 as first-line treatment in East..:

Kang, Yoon-Koo ; Qin, Shukui ; Lee, Keun-Wook...
Gastric Cancer. , 2024

Link: https://doi.org/10.1007/..

4

Bemarituzumab as first-line treatment for locally advanced ..:

Wainberg, Zev A. ; Kang, Yoon-Koo ; Lee, Keun-Wook...
Gastric Cancer. 27 (2024) 3 - p. 558-570 , 2024

Link: https://doi.org/10.1007/..

5

Reactive cutaneous capillary endothelial proliferation foll..:

Qu, Wenshu ; Wang, Feng ; Qin, Shukui..
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

6

Durvalumab or placebo plus gemcitabine and cisplatin in par..:

Oh, Do-Youn ; He, Aiwu Ruth ; Bouattour, Mohamed...
The Lancet Gastroenterology & Hepatology. , 2024

Link: https://doi.org/10.1016/..

7

Tislelizumab versus Sorafenib in First-Line Treatment of Un..:

Finn, Richard S. ; Kudo, Masatoshi ; Barnes, Gisoo...
Liver Cancer. , 2024

Link: https://doi.org/10.1159/..

8

Fruquintinib plus paclitaxel versus placebo plus paclitaxel..:

Wang, Feng ; Shen, Lin ; Guo, Weijian...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

9

A phase IV study to evaluate the safety of fruquintinib in ..:

Li, Jin ; Wang, Zhiqiang ; Zhong, Haijun...
The Oncologist. , 2024

Link: https://doi.org/10.1093/..

10

A Phase 3 Study of Pembrolizumab versus Placebo for Previou..:

Qin, Shukui ; Fang, Weijia ; Ren, Zhenggang...
Liver Cancer. , 2024

Link: https://doi.org/10.1159/..

11

Hetrombopag for the management of chemotherapy-induced thro..:

Qin, Shukui ; Wang, Yusheng ; Yao, Jun...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

12

Characterization of Tumor Responses in Patients with Unrese..:

Finn, Richard S. ; Qin, Shukui ; Piscaglia, Fabio...
Liver Cancer. , 2024

Link: https://doi.org/10.1159/..

13

Impact of primary tumor side on clinical outcomes of first-..:

Qin, Shukui ; Liu, Tianshu ; Xu, Jianming...
Future Oncology. 19 (2023) 15 - p. 1053-1061 , 2023

Link: https://doi.org/10.2217/..

14

Lenvatinib plus pembrolizumab versus lenvatinib plus placeb..:

Llovet, Josep M ; Kudo, Masatoshi ; Merle, Philippe...
The Lancet Oncology. 24 (2023) 12 - p. 1399-1410 , 2023

Link: https://doi.org/10.1016/..

15

Association of tumor response with survival in patients wit..:

Meyer, Tim ; Finn, Richard S. ; Kudo, Masatoshi...
Journal of Hepatology. 78 (2023) - p. S580-S581 , 2023

Link: https://doi.org/10.1016/..